These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20825412)

  • 21. Characterization of tau oligomeric seeds in progressive supranuclear palsy.
    Gerson JE; Sengupta U; Lasagna-Reeves CA; Guerrero-Muñoz MJ; Troncoso J; Kayed R
    Acta Neuropathol Commun; 2014 Jun; 2():73. PubMed ID: 24927818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tau pathology in aged cynomolgus monkeys is progressive supranuclear palsy/corticobasal degeneration- but not Alzheimer disease-like -Ultrastructural mapping of tau by EDX.
    Uchihara T; Endo K; Kondo H; Okabayashi S; Shimozawa N; Yasutomi Y; Adachi E; Kimura N
    Acta Neuropathol Commun; 2016 Nov; 4(1):118. PubMed ID: 27842611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.
    Gibbons GS; Banks RA; Kim B; Changolkar L; Riddle DM; Leight SN; Irwin DJ; Trojanowski JQ; Lee VMY
    J Neuropathol Exp Neurol; 2018 Mar; 77(3):216-228. PubMed ID: 29415231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression patterns of tau mRNA isoforms correlate with susceptible lesions in progressive supranuclear palsy and corticobasal degeneration.
    Takanashi M; Mori H; Arima K; Mizuno Y; Hattori N
    Brain Res Mol Brain Res; 2002 Aug; 104(2):210-9. PubMed ID: 12225876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Argyrophilic grain disease is a sporadic 4-repeat tauopathy.
    Togo T; Sahara N; Yen SH; Cookson N; Ishizawa T; Hutton M; de Silva R; Lees A; Dickson DW
    J Neuropathol Exp Neurol; 2002 Jun; 61(6):547-56. PubMed ID: 12071638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective deposition of 4-repeat tau in cerebral infarcts.
    Ichihara K; Uchihara T; Nakamura A; Suzuki Y; Mizutani T
    J Neuropathol Exp Neurol; 2009 Sep; 68(9):1029-36. PubMed ID: 19680140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
    Ferrer I; Blanco R; Carmona M; Puig B
    J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tau epitope display in progressive supranuclear palsy and corticobasal degeneration.
    Berry RW; Sweet AP; Clark FA; Lagalwar S; Lapin BR; Wang T; Topgi S; Guillozet-Bongaarts AL; Cochran EJ; Bigio EH; Binder LI
    J Neurocytol; 2004 May; 33(3):287-95. PubMed ID: 15475684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy.
    Arai T; Ikeda K; Akiyama H; Shikamoto Y; Tsuchiya K; Yagishita S; Beach T; Rogers J; Schwab C; McGeer PL
    Acta Neuropathol; 2001 Feb; 101(2):167-73. PubMed ID: 11271372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unexpected abundance of pathological tau in progressive supranuclear palsy white matter.
    Zhukareva V; Joyce S; Schuck T; Van Deerlin V; Hurtig H; Albin R; Gilman S; Chin S; Miller B; Trojanowski JQ; Lee VM
    Ann Neurol; 2006 Sep; 60(3):335-45. PubMed ID: 16823854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DJ-1 (PARK7) is associated with 3R and 4R tau neuronal and glial inclusions in neurodegenerative disorders.
    Kumaran R; Kingsbury A; Coulter I; Lashley T; Williams D; de Silva R; Mann D; Revesz T; Lees A; Bandopadhyay R
    Neurobiol Dis; 2007 Oct; 28(1):122-32. PubMed ID: 17719794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease.
    Ishizawa K; Ksiezak-Reding H; Davies P; Delacourte A; Tiseo P; Yen SH; Dickson DW
    Acta Neuropathol; 2000 Sep; 100(3):235-44. PubMed ID: 10965792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias.
    Mott RT; Dickson DW; Trojanowski JQ; Zhukareva V; Lee VM; Forman M; Van Deerlin V; Ervin JF; Wang DS; Schmechel DE; Hulette CM
    J Neuropathol Exp Neurol; 2005 May; 64(5):420-8. PubMed ID: 15892300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies.
    de Silva R; Lashley T; Gibb G; Hanger D; Hope A; Reid A; Bandopadhyay R; Utton M; Strand C; Jowett T; Khan N; Anderton B; Wood N; Holton J; Revesz T; Lees A
    Neuropathol Appl Neurobiol; 2003 Jun; 29(3):288-302. PubMed ID: 12787326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
    Scaravilli T; Tolosa E; Ferrer I
    Mov Disord; 2005 Aug; 20 Suppl 12():S21-8. PubMed ID: 16092076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Arai T; Ikeda K; Akiyama H; Tsuchiya K; Iritani S; Ishiguro K; Yagishita S; Oda T; Odawara T; Iseki E
    Acta Neuropathol; 2003 May; 105(5):489-98. PubMed ID: 12677450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and pathological study of two patients with progressive supranuclear palsy and Alzheimer's changes. Antigenic determinants that distinguish cortical and subcortical neurofibrillary tangles.
    Cruz-Sanchez FF; Rossi ML; Cardozo A; Deacon P; Tolosa E
    Neurosci Lett; 1992 Feb; 136(1):43-6. PubMed ID: 1321966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tau-positive fine granules in the cerebral white matter: a novel finding among the tauopathies exclusive to parkinsonism-dementia complex of Guam.
    Yamazaki M; Hasegawa M; Mori O; Murayama S; Tsuchiya K; Ikeda K; Chen KM; Katayama Y; Oyanagi K
    J Neuropathol Exp Neurol; 2005 Oct; 64(10):839-46. PubMed ID: 16215455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extensive deamidation at asparagine residue 279 accounts for weak immunoreactivity of tau with RD4 antibody in Alzheimer's disease brain.
    Dan A; Takahashi M; Masuda-Suzukake M; Kametani F; Nonaka T; Kondo H; Akiyama H; Arai T; Mann DM; Saito Y; Hatsuta H; Murayama S; Hasegawa M
    Acta Neuropathol Commun; 2013 Aug; 1():54. PubMed ID: 24252707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms.
    Sergeant N; Wattez A; Delacourte A
    J Neurochem; 1999 Mar; 72(3):1243-9. PubMed ID: 10037497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.